| Year |
Citation |
Score |
| 2023 |
Ko JJ, Banerji S, Blais N, Brade A, Clelland C, Schellenberg D, Snow S, Wheatley-Price P, Yuan R, Melosky B. Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current Oncology (Toronto, Ont.). 30: 3817-3828. PMID 37185402 DOI: 10.3390/curroncol30040289 |
0.311 |
|
| 2022 |
Louie AV, Granton PV, Fairchild A, Bezjak A, Gopaul D, Mulroy L, Brade A, Warner A, Debenham B, Bowes D, Kuk J, Sun A, Hoover D, Rodrigues GB, Palma DA. Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 35201290 DOI: 10.1001/jamaoncol.2021.7664 |
0.356 |
|
| 2021 |
Brade A, Jao K, Yu S, Cheema P, Doucette S, Christofides A, Schellenberg D. A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer. Current Oncology (Toronto, Ont.). 28: 1618-1629. PMID 33923355 DOI: 10.3390/curroncol28030151 |
0.344 |
|
| 2020 |
Robinson DAG, Snow S, Brade A, Ho C, Wheatley-Price P, Blais N, Cheema P, Swaminath A. Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations. Cancer Treatment and Research Communications. 25: 100265. PMID 33310367 DOI: 10.1016/j.ctarc.2020.100265 |
0.315 |
|
| 2020 |
Melosky B, Cheema PK, Brade A, McLeod D, Liu G, Wheatley Price P, Jao K, Schellenberg DD, Juergens R, Leighl N, Chu Q. Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer. The Oncologist. PMID 32860288 DOI: 10.1634/Theoncologist.2020-0193 |
0.47 |
|
| 2020 |
Louie A, Granton P, Fairchild A, Bezjak A, Gopaul D, Mulroy L, Brade A, Warner A, Debenham B, Bowes D, Kuk J, Sun A, Hoover D, Rodrigues G, Palma D. 51: A Phase Iii Randomized Trial of Palliative Radiation for Advanced Central Lung Tumours with Intentional Avoidance of the Esophagus (Proactive) Radiotherapy and Oncology. 150: S25-S26. DOI: 10.1016/s0167-8140(20)30943-9 |
0.326 |
|
| 2020 |
Louie A, Granton P, Bezjak A, Fairchild A, Gopaul D, Mulroy L, Brade A, Warner A, Debenham B, Bowes D, Kuk J, Sun A, Hoover D, Rodrigues G, Palma D. A Phase III Randomized Trial of Palliative Radiation for Advanced Central Lung Tumors with Intentional Avoidance of the Esophagus (PROACTIVE) International Journal of Radiation Oncology*Biology*Physics. 108: S105-S106. DOI: 10.1016/j.ijrobp.2020.07.2287 |
0.311 |
|
| 2019 |
Melosky B, Juergens R, McLeod D, Leighl N, Brade A, Card PB, Chu Q. Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 134: 259-267. PMID 31319991 DOI: 10.1016/J.Lungcan.2019.05.027 |
0.436 |
|
| 2019 |
Cheema PK, Rothenstein J, Melosky B, Brade A, Hirsh V. Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer. Current Oncology (Toronto, Ont.). 26: 37-42. PMID 30853796 DOI: 10.3747/Co.25.4096 |
0.482 |
|
| 2019 |
Schuffenegger PM, Barry AS, Atenafu E, Kim J, Brierley J, Ringash JG, Brade A, Wong R, Cho CY, Sapisochin G, Dawson LA. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma with Macrovascular Invasion International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.171 |
0.341 |
|
| 2018 |
Brade AM, Wenz F, Koppe F, Lievens Y, San Antonio B, Iscoe NA, Hossain A, Chouaki N, Senan S. Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial. International Journal of Radiation Oncology, Biology, Physics. 101: 927-934. PMID 29976505 DOI: 10.1016/j.ijrobp.2018.04.015 |
0.362 |
|
| 2018 |
Ponichtera J, Schuffenegger PM, Lindsay P, Panzarella T, Dawson LA, Bezjak A, Brade A, Chung P, Kim J, Hope A, Sun A, Gluliani ME, Brierley J, Koch CA, Cummings BJ, et al. PV-0473: Dosimetry, safety, efficacy and QoL in a study of 5-fraction SBRT for oligometastatic (OM) cancers Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30783-7 |
0.312 |
|
| 2018 |
Ponichtera J, Schuffenegger PM, Lindsay P, Panzarella T, Dawson LA, Bezjak A, Brade A, Chung P, Kim J, Hope AJ, Sun A, Giuliani M, Brierley J, Koch CA, Cummings BJ, et al. Reasons for Screen Failure among Patients Identified as Candidates for a Phase 2 Study of 5-fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Cancer International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1232 |
0.402 |
|
| 2017 |
Brade AM. The rapidly evolving treatment landscape for patients with brain metastases from epidermal growth factor receptor mutated non-small cell lung cancer. Translational Lung Cancer Research. 6: S55-S57. PMID 29299412 DOI: 10.21037/Tlcr.2017.10.14 |
0.372 |
|
| 2017 |
Glick D, Lyen S, Kandel S, Shapera S, Le LW, Lindsay P, Wong O, Bezjak A, Brade A, Cho BCJ, Hope A, Sun A, Giuliani M. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT). Clinical Lung Cancer. PMID 29066051 DOI: 10.1016/j.cllc.2017.06.021 |
0.373 |
|
| 2016 |
Glick D, Lyen S, Le L, Lindsay PE, Wong O, Bezjak A, Brade AM, Cho J, Hope AJ, Sun A, Shapera S, Kandel S, Giuliani ME. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology, Biology, Physics. 96: E431. PMID 27674674 DOI: 10.1016/j.ijrobp.2016.06.1713 |
0.378 |
|
| 2016 |
Barry AS, McPartlin AJ, Lindsay PE, Brierley J, Kim JJ, Ringash JG, Wong R, Dinniwell R, Cummings BJ, Brade AM, Craig T, Dawson LA. Dosimetric Associations With Acute Liver Toxicity in Stereotactic Body Radiation Therapy for Liver Metastases. International Journal of Radiation Oncology, Biology, Physics. 96: E201-E202. PMID 27674049 DOI: 10.1016/J.Ijrobp.2016.06.1098 |
0.314 |
|
| 2016 |
McPartlin AJ, Barry AS, Murray L, Swaminath A, Dinniwell R, Brade AM, Ringash JG, Brierley J, Kim JJ, Wong R, Cummings BJ, Dawson LA. Stereotactic Body Radiation Therapy for Colorectal Liver Metastases-Long-Term Follow-up of a Single Center's Sequential Prospective Studies. International Journal of Radiation Oncology, Biology, Physics. 96: E184. PMID 27673999 DOI: 10.1016/J.Ijrobp.2016.06.1052 |
0.342 |
|
| 2016 |
Hosni A, Cummings BJ, Han K, Le L, Brierley J, Wong R, Dinniwell R, Brade AM, Dawson LA, Ringash JG, Krzyzanowska M, Chen E, Hedley D, Knox J, Easson A, et al. Failure of Standardized High-Dose Radiation (63 Gy/7 weeks) and 2 Cycles of Concurrent 5FU and Mitomycin to Control Large Anal Cancers. International Journal of Radiation Oncology, Biology, Physics. 96: E158-E159. PMID 27673929 DOI: 10.1016/J.Ijrobp.2016.06.990 |
0.377 |
|
| 2016 |
Giuliani M, Sampson LR, Wong O, Gay J, Le LW, Cho BC, Brade A, Sun A, Bezjak A, Hope AJ. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy. Current Oncology (Toronto, Ont.). 23: e362-8. PMID 27536185 DOI: 10.3747/Co.23.3051 |
0.382 |
|
| 2016 |
Brade AM, Ng S, Brierley J, Kim J, Dinniwell R, Ringash J, Wong RR, Cho C, Knox J, Dawson LA. Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics. 94: 580-7. PMID 26867886 DOI: 10.1016/J.Ijrobp.2015.11.048 |
0.364 |
|
| 2016 |
Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, Martinez Aguillo M, Aerts J, Govindan R, Rubio-Viqueira B, Lewanski C, Gandara D, Choy H, Mok T, Hossain A, et al. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26811519 DOI: 10.1200/Jco.2015.64.8824 |
0.452 |
|
| 2016 |
Brade AM, Dawson LA. To RCT or Not to RCT: How to Change Practice for Rare Cancers? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 203-4. PMID 26644540 DOI: 10.1200/Jco.2015.63.8767 |
0.414 |
|
| 2016 |
Barry AS, Sapisochin G, Russo M, Brade AM, Brierley JD, Kim JJ, Greig PD, Grant D, Dawson LA. The use of stereotactic body radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Journal of Clinical Oncology. 34: 418-418. DOI: 10.1200/Jco.2016.34.4_Suppl.418 |
0.333 |
|
| 2016 |
Loveday B, Knox JJ, Dawson LA, May G, Metser U, Brade AM, Horgan AM, Cummings B, Grant D, Gallinger S, Greig PD, Moulton C. Intention to treat analysis of neoadjuvant chemoradiation and liver transplantation for perihilar cholangiocarcinoma. Journal of Clinical Oncology. 34: 394-394. DOI: 10.1200/Jco.2016.34.4_Suppl.394 |
0.384 |
|
| 2016 |
Goody RB, Mackay H, Pitcher B, Oza AM, Brierley JD, Kim JJ, Wong R, Kassam Z, Swallow CJ, Cummings B, Dinniwell RE, Knox JJ, Brade AM, Dawson LA, Pintilie M, et al. Prospective evaluation of quality of life (QOL) during a phase I/II study of adjuvant chemotherapy with image-guided high-precision radiotherapy for completely resected gastric cancer. Journal of Clinical Oncology. 34: 164-164. DOI: 10.1200/Jco.2016.34.4_Suppl.164 |
0.394 |
|
| 2016 |
Glick D, Lyen S, Le L, Lindsay P, Wong O, Bezjak A, Brade A, Cho J, Hope A, Sun A, Shapera S, Kandel S, Giuliani M. 40: Radiation Pneumonitis in Patients with Interstitial Lung Disease Treated with Lung Stereotactic Radiation Therapy Radiotherapy and Oncology. 120. DOI: 10.1016/S0167-8140(16)33439-9 |
0.457 |
|
| 2015 |
Brade A, MacRae R, Laurie SA, Bezjak A, Burkes R, Chu Q, Goffin JR, Cho J, Hope A, Sun A, Leighl N, Capobianco S, Feld R, Mahalingam E, Hossain A, et al. Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer. Clinical Lung Cancer. PMID 26872764 DOI: 10.1016/J.Cllc.2015.12.008 |
0.38 |
|
| 2015 |
Raziee H, Hope A, Faruqi S, Yap ML, Roberts H, Kandel S, Le LW, Brade A, Cho J, Sun A, Bezjak A, Giuliani ME. Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System. Clinical Lung Cancer. PMID 26077096 DOI: 10.1016/J.Cllc.2015.05.008 |
0.405 |
|
| 2015 |
Mehta MP, Wang D, Wang F, Kleinberg L, Brade A, Robins HI, Turaka A, Leahy T, Medina D, Xiong H, Mostafa NM, Dunbar M, Zhu M, Qian J, Holen K, et al. Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study. Journal of Neuro-Oncology. 122: 409-17. PMID 25682091 DOI: 10.1007/s11060-015-1733-1 |
0.334 |
|
| 2015 |
Giuliani ME, Lindsay PE, Kwan JY, Sun A, Bezjak A, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma. Clinical Lung Cancer. 16: 216-20. PMID 25532963 DOI: 10.1016/j.cllc.2014.11.008 |
0.35 |
|
| 2015 |
Senan S, Brade AM, Wang L, Vansteenkiste JF, Dakhil SR, Biesma B, Aguillo MM, Aerts J, Govindan R, Rubio-Viqueira B, Lewanski CR, Gandara DR, Choy H, Mok T, Hossain A, et al. Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsquamous non-small cell lung cancer (nsNSCLC). Journal of Clinical Oncology. 33: 7506-7506. DOI: 10.1200/Jco.2015.33.15_Suppl.7506 |
0.332 |
|
| 2015 |
Sole C, Hope A, Dayyat A, Sun A, Cho J, Wong O, Lee L, Brade A, Bezjak A, Giuliani M. Safety and Outcomes of Multiple Courses of Stereotactic Body Radiation Therapy to the Lung International Journal of Radiation Oncology*Biology*Physics. 93: E444. DOI: 10.1016/J.IJROBP.2015.07.1679 |
0.318 |
|
| 2015 |
Yau V, Giuliani M, Wong O, Le L, Darling G, Shepherd F, Brade A, Cho J, Sun A, Bezjak A, Hope A. Outcomes in Patients With Stage III Non-Small Cell Lung Cancer Treated With Neoadjuvant Concurrent Chemotherapy and Radiation Therapy Followed by Surgical Resection International Journal of Radiation Oncology*Biology*Physics. 93: E414. DOI: 10.1016/J.IJROBP.2015.07.1602 |
0.422 |
|
| 2014 |
Faruqi S, Giuliani ME, Raziee H, Yap ML, Roberts H, Le LW, Brade A, Cho J, Sun A, Bezjak A, Hope AJ. Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 89: 1076-83. PMID 25035211 DOI: 10.1016/j.ijrobp.2014.04.042 |
0.313 |
|
| 2014 |
Lao L, Hope AJ, Maganti M, Brade A, Bezjak A, Saibishkumar EP, Giuliani M, Sun A, Cho BC. Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with SBRT: a case-matched analysis. International Journal of Radiation Oncology, Biology, Physics. 90: 209-15. PMID 24997639 DOI: 10.1016/j.ijrobp.2014.05.006 |
0.405 |
|
| 2014 |
Atallah S, Cho BC, Allibhai Z, Taremi M, Giuliani M, Le LW, Brade A, Sun A, Bezjak A, Hope AJ. Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 89: 532-8. PMID 24929163 DOI: 10.1016/J.Ijrobp.2014.03.003 |
0.45 |
|
| 2014 |
Culleton S, Jiang H, Haddad CR, Kim J, Brierley J, Brade A, Ringash J, Dawson LA. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 412-7. PMID 24906626 DOI: 10.1016/J.Radonc.2014.05.002 |
0.302 |
|
| 2014 |
Thompson R, Giuliani M, Yap ML, Atallah S, Le LW, Sun A, Brade A, Cho BC, Bezjak A, Hope A. Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 843-7. PMID 24828663 DOI: 10.1097/Jto.0000000000000159 |
0.447 |
|
| 2014 |
Klein J, Dawson LA, Tran TH, Adeyi O, Purdie T, Sherman M, Brade A. Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy. Current Oncology (Toronto, Ont.). 21: e340-4. PMID 24764717 DOI: 10.3747/Co.21.1756 |
0.371 |
|
| 2014 |
Youl M, Hashem S, Brade A, Cummings B, Dawson LA, Gallinger S, Hedley D, Jiang H, Kim J, Krzyzanowska MK, Ringash J, Wong R, Brierley J. Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)). 26: 203-9. PMID 24462333 DOI: 10.1016/J.Clon.2014.01.003 |
0.317 |
|
| 2014 |
Zer A, Cutz J, Sekhon HS, Hwang DM, Sit C, Binnie M, Brade AM, Chung T, Kamel-Reid S, Narinder P, Tsao M, Waddell TK, Santos GdC, Patel M, Carter RF, et al. A targeted intervention to improve awareness to molecular testing in NSCLC. Journal of Clinical Oncology. 32: 6547-6547. DOI: 10.1200/Jco.2014.32.15_Suppl.6547 |
0.302 |
|
| 2014 |
Reiss KA, Herman JM, Zahurak M, Brade AM, Dawson LA, Scardina A, Joffe C, Petito E, Hacker-Prietz A, Chen AP, Temkin SM, Horiba N, Siu LL, Azad NS. A phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis. Journal of Clinical Oncology. 32: 4139-4139. DOI: 10.1200/Jco.2014.32.15_Suppl.4139 |
0.371 |
|
| 2013 |
Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 1064-70. PMID 24210082 DOI: 10.1016/j.ijrobp.2013.08.020 |
0.327 |
|
| 2013 |
Soliman H, Ringash J, Jiang H, Singh K, Kim J, Dinniwell R, Brade A, Wong R, Brierley J, Cummings B, Zimmermann C, Dawson LA. Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3980-6. PMID 24062394 DOI: 10.1200/Jco.2013.49.9202 |
0.339 |
|
| 2013 |
Tang B, Giuliani M, Le LW, Higgins J, Bezjak A, Brade A, Cho BC, Sun A, Hope AJ. Capturing acute toxicity data during lung radiotherapy by using a patient-reported assessment tool. Clinical Lung Cancer. 14: 108-12. PMID 22885348 DOI: 10.1016/J.Cllc.2012.06.003 |
0.359 |
|
| 2013 |
Culleton S, Jiang H, Kim JJ, Brierley JD, Brade AM, Ringash J, Dawson LA. Outcomes following stereotactic body radiotherapy for patients with Child-Pugh B/C hepatocellular carcinoma. Journal of Clinical Oncology. 31: 167-167. DOI: 10.1200/Jco.2013.31.4_Suppl.167 |
0.324 |
|
| 2012 |
Yung T, Giuliani ME, Le LW, Sun A, Cho BC, Bezjak A, Brade A, Hope AJ. Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer. Current Oncology (Toronto, Ont.). 19: e264-9. PMID 22876155 DOI: 10.3747/Co.19.976 |
0.468 |
|
| 2012 |
Clarke K, Taremi M, Dahele M, Freeman M, Fung S, Franks K, Bezjak A, Brade A, Cho J, Hope A, Sun A. Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome? Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 104: 62-6. PMID 22682749 DOI: 10.1016/J.Radonc.2012.04.019 |
0.389 |
|
| 2012 |
Lavoie C, Higgins J, Bissonnette JP, Le LW, Sun A, Brade A, Hope A, Cho J, Bezjak A. Volumetric image guidance using carina vs spine as registration landmarks for conventionally fractionated lung radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 84: 1086-92. PMID 22494582 DOI: 10.1016/J.Ijrobp.2012.02.012 |
0.41 |
|
| 2012 |
Giuliani ME, Lindsay PE, Sun A, Bezjak A, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ. Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 102: 263-7. PMID 22285072 DOI: 10.1016/J.Radonc.2011.12.009 |
0.382 |
|
| 2012 |
Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. International Journal of Radiation Oncology, Biology, Physics. 82: 967-73. PMID 21377293 DOI: 10.1016/J.Ijrobp.2010.12.039 |
0.47 |
|
| 2012 |
Mehta MP, Curran WJ, Wang D, Wang F, Kleinberg L, Brade AM, Mostafa N, Zhou X, Qian J, Leahy T, Desai B, Giranda VL. Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases. Journal of Clinical Oncology. 30: 2013-2013. DOI: 10.1200/Jco.2012.30.15_Suppl.2013 |
0.349 |
|
| 2012 |
Mehta M, Curran W, Wang D, Wang F, Kleinberg L, Brade A, Qian J, Leahy, T, Desai B, Giranda V. Phase 1 Study of Veliparib With Concurrent Whole Brain Radiation Therapy (WBRT) in Patients (PTS) With Brain Metastases (METS) Annals of Oncology. 23: ix148-ix149. DOI: 10.1016/S0923-7534(20)32987-2 |
0.364 |
|
| 2012 |
Mehta MP, Curran WJ, Wang D, Wang F, Kleinberg L, Brade A, Mostafa N, Qian J, Leahy T, Desai B. Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain Metastases International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.702 |
0.337 |
|
| 2012 |
McCloskey PM, Atallah S, Coate L, Albert-Green A, Hope AJ, Cho J, Brade AM, Sun A, Shepherd FA, Bezjak A. Comparison of 3D Conformal Radiation Therapy (3DCRT) and Intensity Modulated Radiation Therapy (IMRT) in Stage III Non-small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1594 |
0.469 |
|
| 2012 |
Brade AM, Kim J, Brierley J, Dinniwell R, Wong R, Cho C, Kassam Z, Joshua A, Knox J, Dawson L. Phase I Study of Sorafenib and Whole-liver Radiation Therapy (WLRT) or Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.035 |
0.352 |
|
| 2012 |
Soliman H, Ringash J, Jiang H, Singh K, Kim J, Dinniwell R, Brade A, Wong R, Brierley J, Dawson LA. Phase II Trial of Palliative Radiation Therapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.031 |
0.314 |
|
| 2011 |
Brade AM, Kim SW, Chung C, Wan JF, Southwood B, Chaudary N, Wang L, Milosevic M, Oza AM. Final results: A phase I study of sorafenib and palliative radiation in patients with malignancy in the thorax, abdomen, or pelvis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13602. PMID 28023526 DOI: 10.1200/Jco.2011.29.15_Suppl.E13602 |
0.397 |
|
| 2011 |
Giuliani ME, Atallah S, Sun A, Bezjak A, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Clinical Lung Cancer. 12: 375-9. PMID 21729647 DOI: 10.1016/J.Cllc.2011.03.028 |
0.41 |
|
| 2011 |
Lim G, Bezjak A, Higgins J, Moseley D, Hope AJ, Sun A, Cho JB, Brade AM, Ma C, Bissonnette JP. Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 531-6. PMID 21258244 DOI: 10.1097/Jto.0B013E31820B8A52 |
0.436 |
|
| 2011 |
Coate LE, Massey C, Hope A, Sacher A, Barrett K, Pierre A, Leighl N, Brade A, de Perrot M, Waddell T, Liu G, Feld R, Burkes R, Cho BC, Darling G, et al. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 537-44. PMID 21258243 DOI: 10.1097/Jto.0B013E31820B8B9B |
0.418 |
|
| 2011 |
Dahele M, Freeman M, Pearson S, Brade A, Cho BC, Hope A, Franks K, Purdie T, Bissonnette JP, Jaffray DA, Bezjak A, Sun A. Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography. Clinical Oncology (Royal College of Radiologists (Great Britain)). 23: 359-63. PMID 21194908 DOI: 10.1016/J.Clon.2010.11.009 |
0.354 |
|
| 2011 |
Li W, Purdie TG, Taremi M, Fung S, Brade A, Cho BC, Hope A, Sun A, Jaffray DA, Bezjak A, Bissonnette JP. Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patients. International Journal of Radiation Oncology, Biology, Physics. 81: 1568-75. PMID 21075559 DOI: 10.1016/J.Ijrobp.2010.09.035 |
0.385 |
|
| 2011 |
Higgins J, Bezjak A, Hope A, Panzarella T, Li W, Cho JBC, Craig T, Brade A, Sun A, Bissonnette J. Effect of image-guidance frequency on geometric accuracy and setup margins in radiotherapy for locally advanced lung cancer. International Journal of Radiation Oncology Biology Physics. 80: 1330-1337. PMID 20643515 DOI: 10.1016/J.Ijrobp.2010.04.006 |
0.344 |
|
| 2011 |
Brade A, Bezjak A, MacRae R, Laurie S, Sun A, Cho J, Leighl N, Pearson S, Southwood B, Wang L, McGill S, Iscoe N, Shepherd FA. Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 79: 1395-401. PMID 20605367 DOI: 10.1016/J.Ijrobp.2010.01.014 |
0.442 |
|
| 2011 |
Bebb G, Smith C, Rorke S, Boland W, Nicacio L, Sukhoo R, Brade A. Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Cancer Chemotherapy and Pharmacology. 67: 837-45. PMID 20563810 DOI: 10.1007/S00280-010-1379-9 |
0.475 |
|
| 2011 |
You B, Brade A, Magalhaes JM, Siu LL, Oza A, Lovell S, Wang L, Hedley DW, Nicacio LV, Chen EX. A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies Investigational New Drugs. 29: 996-1003. PMID 20454832 DOI: 10.1007/S10637-010-9444-0 |
0.361 |
|
| 2011 |
Allibhai Z, Bezjak A, Atallah S, Hope A, Brade A, Sun A, Taremi M, Swaminath A, Cho BCJ. Impact of Tumor Size and Volume on Outcomes following Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1096 |
0.473 |
|
| 2011 |
Giuliani ME, Yung T, Le LW, Sun A, Cho J, Bezjak A, Brade A, Hope AJ. Clinical Outcomes In Stage I Non-small Cell Lung Cancer Patients Managed With Accelerated Hypofractionated Radiotherapy International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1095 |
0.453 |
|
| 2010 |
Giuliani M, Sun A, Bezjak A, Ma C, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ. Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer. 116: 5694-9. PMID 20803612 DOI: 10.1002/Cncr.25341 |
0.404 |
|
| 2010 |
Clarke K, Taremi M, Freeman M, Fung S, Dahele M, Bezjak A, Brade A, Cho J, Hope A, Sun A. Stereotactic Body Radiotherapy (SBRT) for Non-small Cell Lung Cancer (NSCLC) -is FDG-PET a Predictor of Outcome? International Journal of Radiation Oncology*Biology*Physics. 78: S499-S500. DOI: 10.1016/J.Ijrobp.2010.07.1168 |
0.44 |
|
| 2010 |
Giuliani ME, Lindsay PE, Sun A, Bezjak A, Le LW, Brade A, Cho J, Leighl N, Shepherd FA, Hope AJ. Patterns of Failure in Patients with Limited-Stage Small Cell Lung Carcinoma International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1159 |
0.413 |
|
| 2009 |
Voroney JP, Hope A, Dahele MR, Purdie TG, Purdy T, Franks KN, Pearson S, Cho JB, Sun A, Payne DG, Bissonnette JP, Bezjak A, Brade AM. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 4: 1035-7. PMID 19633478 DOI: 10.1097/Jto.0B013E3181Ae2962 |
0.392 |
|
| 2009 |
Dahele M, Brade A, Pearson S, Bezjak A. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer Canadian Medical Association Journal. 180: 1326-1328. PMID 19546457 DOI: 10.1503/Cmaj.081291 |
0.484 |
|
| 2009 |
Lavoie C, Migchielsen J, Lim G, Vines D, Breen S, Freeman M, Bezjak A, Cho J, Brade A, Hope A, Aerts H, Dekker A, Sun A. 85 PRE-RADIATION TREATMENT PET/CT SCAN CAN PREDICT THE LOCALIZATION OF RESIDUAL DISEASE POST-TREATMENT IN LUNG CANCER Radiotherapy and Oncology. 92: S27. DOI: 10.1016/S0167-8140(12)72472-6 |
0.397 |
|
| 2009 |
Giuliani M, Hope A, Sun A, Ma C, Brade A, Cho J, Bezjak A. 84 Factors Influencing Prophylactic Cranial Irradiation Utilization In Limited Stage Small Cell Lung Cancer Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72471-4 |
0.362 |
|
| 2009 |
Li W, Bezjak A, Purdie T, Taremi M, Hope A, Brade A, Sun A, Cho J, Jaffray D, Bissonnette JP. 82 Assessment Of Intra-Fraction Target Position Accuracy For Lung Stereotactic Body Radiotherapy (Sbrt) Using Cone-Beam Ct (Cbct) Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72469-6 |
0.364 |
|
| 2009 |
Higgins J, Bezjak A, Hope A, Panzarella T, Li W, Craig T, Brade A, Sun A, Cho J, Bissonnette JP. 15 Impact Of Daily Volumetric Imaging In Reducing Set-Up Margins For Lung Cancer Patients Treated With Conventionally Fractionated Radiotherapy Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72402-7 |
0.453 |
|
| 2009 |
Taremi M, Pearson S, Dahele M, Fung S, Bissonnette J-, Purdie T, Franks K, Brade A, Cho J, Hope A, Sun A, Bezjak A. 12 Princess Margaret Hospital Experience With Lung Stereotactic Body Radiotherapy For Early Stage Nonsmall Cell Lung Cancer Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72399-X |
0.437 |
|
| 2009 |
Lavoie C, Higgins J, Bissonnette J-, Brade A, Cho J, Hope A, Sun A, Le LW, Bezjak A. 11 Improvement Of Target Coverage In Radical Lung Radiotherapy Using Image Guidance Cone-Beam Ct (Cbct) Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72398-8 |
0.351 |
|
| 2009 |
Hope AJ, Giuliani M, Ma C, Bezjak A, Sun A, Brade A, Cho BJ, Leighl N, Shepherd F, Lindsay PE. Dosimetric and Clinical Parameters Contributing to Esophagitis and Radiation Pneumonitis following Treatment for Small-cell Lung Carcinoma International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.379 |
0.388 |
|
| 2009 |
Li W, Bezjak A, Purdie TG, Taremi M, Hope A, Brade A, Sun A, Cho J, Jaffray DA, Bissonnette J. Intrafractional Target Position Accuracy for Lung Stereotactic Body Radiotherapy (SBRT) using Cone-beam CT (CBCT) International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.376 |
0.36 |
|
| 2009 |
Higgins JA, Bezjak A, Hope A, Panzarella T, Li W, Craig T, Brade A, Sun A, Cho J, Bissonnette J. Impact of Different Image-guided Protocols on Geometric Accuracy of Radiotherapy for Locally-advanced Lung Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.240 |
0.43 |
|
| 2009 |
Taremi M, Dahele M, Purdie T, Jp JB, Fung S, Brade A, Cho J, Hope A, Sun A, Bezjak A. Patterns of Failure and Salvage Therapy in Stereotactic Body Radiotherapy for Stage I Non–small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1010 |
0.46 |
|
| 2009 |
Lavoie C, Higgins J, Bissonnette J, Sun A, Brade A, Hope A, Cho J, Le L, Bezjak A. Assessing the Accuracy of the Carina as a Landmark for Image Matching using Cone-beam CT in Radical Lung Radiotherapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.1005 |
0.355 |
|
| 2009 |
Giuliani ME, Hope A, Sun A, Ma C, Payne D, Brade A, Cho J, Shepherd F, Leighl N, Bezjak A. Survival Impact of Prophylactic Cranial Irradiation in Limited-stage Small-cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.100 |
0.463 |
|
| 2008 |
Bebb DG, Brade AM, Smith C, Rorke S, Sherman I. Preliminary results of an escalating dose phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab in combination with external radiotherapy in patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3037. PMID 27947572 DOI: 10.1200/Jco.2008.26.15_Suppl.3037 |
0.47 |
|
| 2008 |
Brade AM, Bezjak A, MacRae R, Laurie SA, Pond GR, Wang L, Dick C, Afinec A, Iscoe N, Shepherd FA. A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7550. PMID 27947233 DOI: 10.1200/jco.2008.26.15_suppl.7550 |
0.34 |
|
| 2008 |
Dahele M, Pearson S, Franks K, Purdie T, Bissonnette J, Brade AM, Cho J, Sun A, Jaffray D, Bezjak A. Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7529. PMID 27947204 DOI: 10.1200/Jco.2008.26.15_Suppl.7529 |
0.498 |
|
| 2008 |
Dahele M, Pearson S, Purdie T, Bissonnette JP, Franks K, Brade A, Cho J, Sun A, Hope A, Marshall A, Higgins J, Bezjak A. Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 1332-41. PMID 18978570 DOI: 10.1097/Jto.0B013E31818B1771 |
0.477 |
|
| 2008 |
Wan J, Milosevic M, Brade AM. Use of palliative radiotherapy trials for clinical biomarker development. Cancer Metastasis Reviews. 27: 435-43. PMID 18392923 DOI: 10.1007/S10555-008-9132-0 |
0.365 |
|
| 2008 |
Brade AM, Bezjak A, MacRae R, Laurie SA, Pond GR, Wang L, Dick C, Afinec A, Iscoe N, Shepherd FA. A phase I study of concurrent pemetrexed (P)/cisplatin (C)/radiation (RT) for unresectable stage IIIA/B non-small cell lung cancer (NSCLC) Journal of Clinical Oncology. 26: 7550-7550. DOI: 10.1200/Jco.2010.28.15_Suppl.7087 |
0.47 |
|
| 2008 |
Voroney JPJ, Hope A, Dahele MR, Brade AM, Purdie TG, Franks KN, Pearson S, Cho BC, Bissonnette JP, Bezjak A. Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non-small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.845 |
0.377 |
|
| 2008 |
Vallis K, Reilly R, Scollard D, Merante P, Freeman M, Lockwood G, Sabate K, Brade A. A Phase I Trial of 111In-human Epidermal Growth Factor in Patients with Metastatic EGFR-positive Breast Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S178-S179. DOI: 10.1016/J.Ijrobp.2008.06.740 |
0.319 |
|
| 2008 |
Brade AM, Bebb G, Smith C, Rorke S, Sherman I. Concurrent and Adjuvant Nimotuzumab Combined with Palliative Thoracic Radiation for Patients with Stage IIb/III/IV Non-small Cell Lung Cancer: A Phase I Study International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.405 |
0.508 |
|
| 2008 |
Sun A, Lim G, Wysocka B, Vines D, Freeman M, Bezjak A, Cho J, Brade A, Hope A, Breen S. A Pilot Prospective Study of Metabolic and Anatomic Response using FDG PET CT before, during and after Radiotherapy in Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 72: S459. DOI: 10.1016/J.Ijrobp.2008.06.1854 |
0.359 |
|
| 2008 |
Cho BJ, Bezjak A, Brade A, Hope A, Sun A. Quantifying the Benefits of Adaptive Radiotherapy on Lung Sparing for Thoracic Tumors International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1826 |
0.38 |
|
| 2008 |
Dahele M, Freeman M, Pearson S, Purdie T, Sun A, Brade A, Cho J, Hope A, Bissonnette J, Bezjak A. Investigating the Early Metabolic Response of Non-small Cell Lung Cancer (NSCLC) to Stereotactic Body Radiation Therapy (SBRT) International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1809 |
0.478 |
|
| 2008 |
Lim GW, Bezjak A, Higgins J, Moseley D, Hope AJ, Cho JBC, Sun A, Brade A, Le L, Bissonnette J. Respiratory Correlated Cone Beam CT in the Assessment of Non-small Cell Lung Cancer during Radiotherapy International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1353 |
0.411 |
|
| 2007 |
Brade A, Brierley J, Oza A, Gallinger S, Cummings B, Maclean M, Pond GR, Hedley D, Wong S, Townsley C, Brezden-Masley C, Moore M. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study. International Journal of Radiation Oncology, Biology, Physics. 67: 1027-36. PMID 17197132 DOI: 10.1016/J.Ijrobp.2006.10.015 |
0.371 |
|
| 2007 |
Franks KN, Bezjak A, Higgins J, Li W, Purdie TG, Brade A, Cho J, Payne D, Jaffray DA, Bissonnette J. Image-guided lung radiotherapy: Bringing technology into routine clinical practice Journal of Clinical Oncology. 25: 18093-18093. DOI: 10.1200/Jco.2007.25.18_Suppl.18093 |
0.377 |
|
| 2007 |
Brade AM, Magalhaes J, Siu L, Oza A, Lovell S, de Borja M, Pond G, Sherman I, Hedley D, Chen E. A single agent, phase I pharmacodynamic study of nimotuzumab (TheraCIM-h-R3) in patients with advanced refractory solid tumors Journal of Clinical Oncology. 25: 14030-14030. DOI: 10.1200/Jco.2007.25.18_Suppl.14030 |
0.374 |
|
| 2007 |
Sun A, Wysocka B, Pearson S, Kane G, Payne D, Cho J, Brade A, Bezjak A. P3-198: An audit of elective mediastinal lymph node irradiation in stage III non-small cell lung cancer patients entered onto a prospective randomized phase III study Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000284173.03442.81 |
0.424 |
|
| 2007 |
Brade AM, Bezjak A, MacRae R, Laurie S, Afinec A, Pond G, Iscoe N, Shepherd FA. P2-165: A phase I/II study of concurrent pemetrexed/cisplatin/radiation in stage IIIa/b non-small cell lung cancer Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283823.54863.21 |
0.464 |
|
| 2007 |
Bebb G, Smith C, O'Rourke K, Brade A, Sherman I. P3-023: Preliminary results of an escalating dose phase I /II clinical trial of the anti EGFR monoclonal antibody nimotuzumab in combination with external radiotherapy in patients diagnosed with stage IIB, III or IV NSCLC unsuitable for radical therapy Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283780.87833.C2 |
0.387 |
|
| 2007 |
Bezjak A, Franks K, Purdie T, Pearson S, Brade A, Cho J, Kane G, Sun A, David P, Bissonnette J. PD5-2-3: Translating research into routine clinical practice: image-guided lung stereotactic radiation therapy for unresectable patients with early stage lung cancer Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283429.66767.D1 |
0.455 |
|
| 2007 |
Brade A, Bezjak A, MacRae R, Laurie S, Pond G, Afinec A, Iscoe N, Shepherd F. 6550 POSTER A phase I study of concurrent pemetrexed/cisplatin/radiation for unresectable stage IIIA/B non-small cell lung cancer Ejc Supplements. 5: 373. DOI: 10.1016/S1359-6349(07)71378-2 |
0.481 |
|
| 2007 |
Brade AM, Bezjak A, MacRae R, Laurie S, Pond GR, Afinec A, Iscoe N, Shepherd F. Concurrent Pemetrexed/Cisplatin/Radiation for Unresectable Stage IIIA/B Non-Small Cell Lung Cancer: A Phase I/II Study International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1698 |
0.471 |
|
| 2007 |
Franks KN, Bezjak A, Purdie TG, Bissonnette J-, Pearson S, Payne D, Cho J, Kane G, Sun A, Brade A, Jaffray DA. Early Results of Image-guided Radiation Therapy in Lung Stereotactic Body Radiotherapy (SBRT) Clinical Oncology. 19. DOI: 10.1016/J.Clon.2007.01.302 |
0.446 |
|
| 2006 |
Brade AM, Tannock IF. Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1020-2. PMID 16505418 DOI: 10.1200/Jco.2005.04.9676 |
0.459 |
|
| 2006 |
Townsley C, Brade AM, Brezden-Masley C, Hedley D, Gallinger S, Pond GR, Oza AM, Brierley J, Moore MJ. Long-term results of concurrent gemcitabine (G) and radiotherapy (GRT) for locally advanced (LA) or high-risk resected (R) pancreatic cancer Journal of Clinical Oncology. 24: 4101-4101. DOI: 10.1200/Jco.2006.24.18_Suppl.4101 |
0.38 |
|
| 2006 |
Brade A, Townsley C, Brezden-Masley C, Hedley D, MacLean M, Gallinger S, Pond G, Oza A, Moore M, Brierley J. 63 Primary and adjuvant chemoradiotherapy for locally advanced pancreatic cancer: A phase I/II study with long term outcome Radiotherapy and Oncology. 80: S19. DOI: 10.1016/S0167-8140(06)80804-2 |
0.326 |
|
| 2005 |
Brade A, O'Sullivan B, Cummings B, Quirt I. A positive prognosis. Canadian Medical Association Journal. 173: 1206-1206. PMID 16275975 DOI: 10.1503/Cmaj.1050141 |
0.341 |
|
| 2004 |
Ma N, Szmitko P, Brade A, Chu I, Lo A, Woodgett J, Klamut H, Liu FF. Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer. Cancer Gene Therapy. 11: 52-60. PMID 14681726 DOI: 10.1038/Sj.Cgt.7700655 |
0.306 |
|
| 2003 |
Brade AM, Szmitko P, Ngo D, Liu FF, Klamut HJ. Heat-directed suicide gene therapy for breast cancer. Cancer Gene Therapy. 10: 294-301. PMID 12679802 DOI: 10.1038/Sj.Cgt.7700570 |
0.317 |
|
| 2001 |
Brade AM, Szmitko P, Russell SJ, Klamut HJ, Liu FF. Heat-directed cell fusion as a novel anti-cancer therapy International Journal of Radiation Oncology Biology Physics. 51: 184. DOI: 10.1016/S0360-3016(01)02157-5 |
0.325 |
|
| 1998 |
Brade AM, Klamut HJ, Liu F. Heat-directed cancer gene therapy International Journal of Radiation Oncology Biology Physics. 42: 228. DOI: 10.1016/S0360-3016(98)80308-8 |
0.309 |
|
| Show low-probability matches. |